Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Acetylcysteine/pentoxifylline

Next Previous
Drug Profile

Acetylcysteine/pentoxifylline

Alternative Names: Acetylcysteine/oxpentifylline; Oxpentifylline/acetylcysteine; Pentoxifylline/acetylcysteine; PTL-202

Latest Information Update: 28 Jul 2018

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pacific Therapeutics
  • Class Antifibrotics; Reducing agents; Small molecules; Sulfur amino acids; Xanthines
  • Mechanism of Action Antioxidants; Cytokine inhibitors; Free radical scavengers; Phosphoric diester hydrolase inhibitors; Platelet aggregation inhibitors; Transforming growth factor beta inhibitors; Tumour necrosis factor inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Idiopathic pulmonary fibrosis

Most Recent Events

  • 28 Jul 2018 No recent reports of development identified for phase-I development in Idiopathic-pulmonary-fibrosis(In volunteers) in India (PO, Tablet)
  • 08 May 2014 Acetylcysteine/pentoxifylline is still in phase I trials for Pulmonary fibrosis
  • 04 Feb 2014 Pacific Therapeutics terminates its technology licence with Dalhousie University in Canada

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top